511 related articles for article (PubMed ID: 2470098)
1. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.
Barber EK; Dasgupta JD; Schlossman SF; Trevillyan JM; Rudd CE
Proc Natl Acad Sci U S A; 1989 May; 86(9):3277-81. PubMed ID: 2470098
[TBL] [Abstract][Full Text] [Related]
2. The CD4/CD8:p56lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth.
Rudd C; Helms S; Barber EK; Schlossman SF
Biochem Cell Biol; 1989 Sep; 67(9):581-9. PubMed ID: 2508730
[TBL] [Abstract][Full Text] [Related]
3. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
Thome M; Duplay P; Guttinger M; Acuto O
J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens.
Rudd CE; Barber EK; Burgess KE; Hahn JY; Odysseos AD; Sy MS; Schlossman SF
Adv Exp Med Biol; 1991; 292():85-96. PubMed ID: 1835265
[TBL] [Abstract][Full Text] [Related]
5. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
6. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation.
Rudd CE; Anderson P; Morimoto C; Streuli M; Schlossman SF
Immunol Rev; 1989 Oct; 111():225-66. PubMed ID: 2534114
[TBL] [Abstract][Full Text] [Related]
7. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
Thome M; Germain V; DiSanto JP; Acuto O
Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
[TBL] [Abstract][Full Text] [Related]
8. CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.
Sancho J; Ledbetter JA; Choi MS; Kanner SB; Deans JP; Terhorst C
J Biol Chem; 1992 Apr; 267(11):7871-9. PubMed ID: 1532798
[TBL] [Abstract][Full Text] [Related]
9. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.
Raab M; Yamamoto M; Rudd CE
Mol Cell Biol; 1994 May; 14(5):2862-70. PubMed ID: 7513045
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
Abraham N; Miceli MC; Parnes JR; Veillette A
Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
[TBL] [Abstract][Full Text] [Related]
11. Requirement for kinase activity of CD4-associated p56lck in antibody-triggered T cell signal transduction.
Chu K; Littman DR
J Biol Chem; 1994 Sep; 269(39):24095-101. PubMed ID: 7929062
[TBL] [Abstract][Full Text] [Related]
12. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.
Rudd CE; Trevillyan JM; Dasgupta JD; Wong LL; Schlossman SF
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5190-4. PubMed ID: 2455897
[TBL] [Abstract][Full Text] [Related]
13. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.
Danielian S; Fagard R; Alcover A; Acuto O; Fischer S
Eur J Immunol; 1989 Dec; 19(12):2183-9. PubMed ID: 2481585
[TBL] [Abstract][Full Text] [Related]
14. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.
Luo KX; Sefton BM
Mol Cell Biol; 1990 Oct; 10(10):5305-13. PubMed ID: 2118992
[TBL] [Abstract][Full Text] [Related]
16. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck.
Ostergaard HL; Trowbridge IS
J Exp Med; 1990 Jul; 172(1):347-50. PubMed ID: 2141630
[TBL] [Abstract][Full Text] [Related]
17. Delayed thymocyte development induced by augmented expression of p56lck.
Abraham KM; Levin SD; Marth JD; Forbush KA; Perlmutter RM
J Exp Med; 1991 Jun; 173(6):1421-32. PubMed ID: 1709675
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
[TBL] [Abstract][Full Text] [Related]
19. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
[TBL] [Abstract][Full Text] [Related]
20. Identification of distinct populations of PI-3 kinase activity following T-cell activation.
Thompson PA; Gutkind JS; Robbins KC; Ledbetter JA; Bolen JB
Oncogene; 1992 Apr; 7(4):719-25. PubMed ID: 1373484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
